Document is current
Any future updates will be listed below
-
Authors
Kovatchev, Boris https://orcid.org/0000-0003-0495-3901
-
Funding
Funding for this research was provided by:
University of Virginia’s Precision Individualized Medicine for Diabetes (PrIMeD) Project (88)
- License Information
-
More Information
Article History
Received: 27 August 2018
Accepted: 8 October 2018
First Online: 7 November 2018
Ethics approval and consent to participate
: Not Applicable.
: Not Applicable.
: The author reports patents and patent applications related to diabetes technology managed by the University of Virginia Licensing and Ventures group; Research support managed by the University of Virginia from: Dexcom, Roche Diagnostics, Tandem Diabetes Care; Speaking Engagement/Advisory panel/Consultant: Dexcom, Sanofi Aventis; Formerly: Board member and shareholder, TypeZero Technologies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
